Where does Allergan, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Allergan, Inc. ranks #745 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Allergan, Inc. hold?

Allergan, Inc. holds 612 US utility patents granted between 2015 and 2025, spanning 57 technology areas.

What is Allergan, Inc.'s Innovation Score?

Allergan, Inc. has an Innovation Score of 55.5 out of 100 (top 7% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Allergan, Inc. focus on?

Allergan, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 415 patents, ranking #26 of 6,058 assignees active in that subclass. Grants appear in 57 CPC subclasses total.

Is Allergan, Inc.'s patent grant rate increasing or decreasing?

Allergan, Inc.'s recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Allergan, Inc.'s patents?

Allergan, Inc.'s patents average 11.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Allergan, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Allergan, Inc.

USPTO PatentsView assignee record - 612 granted patents across 57 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Allergan ranks #745 of 49,997 tracked US assignees by granted-patent volume, with 612 patents across 57 technology areas.

#745
of 49,997 US assignees by volume: Top 7%
by Innovation Score (55.5/100): 11.5
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R745 · US Corporation #745 · 612 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 612 grants
TOP-DECILE #745/49,997
PHOTO-FINISH Ford Motor
CPC-WIDE A61P · 57 areas
INNOV-PAR 55.5/100
CLAIMS-PAR 11.5 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ford Motor Company (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Allergan’s 55.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 22.2 pts (40%) Velocity 1.4 pts (3%) Breadth 25.0 pts (45%) Claim depth 6.9 pts (12%)

Qualcomm Incorporated · highest

85
Melexis · near

55
The United States… · near

55
Allergan · this assignee

55
Hankook Tire &… · near

55
Kelk · near

55
3D Lighting… · lowest

7

What this shows Allergan's Innovation Score is 55.5/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Allergan?

Each dot is one of Allergan’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Allergan’s own 11.5 claims/patent is at or below the 11.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Allergan vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Allergan's grant cadence moved

Between 2020–2024, Allergan, Inc. received 120 grants versus 489 in 2015–2019 (-75% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2015 at 141 grants and bottomed in 2023 at 7. Lead class A61P accounts for 67.8% of the portfolio across 57 subclasses. Volume neighbours: Suzuki Motor Corporation (#741) and Renault S.A.S. (#749).

Allergan's three-year grant acceleration

From 2019–2021 to 2022–2024, Allergan, Inc. moved from 156 to 32 grants (0.20x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #3,086. See the growth leaderboard.

Suzuki Motor

616
Uchicago Argonne

616
Fresenius Medical…

615
Dexerials

614
Ford Motor

612
Spectrum Brands

612
Allergan ◀

612
Yahoo Holdings

611
Renault S

610

What this shows Allergan holds 612 patents at rank #745, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Allergan

By rank, the assignees closest to #745 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Allergan's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Allergan, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Allergan ranks #26 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (55 here).

Kelk Ltd. 55 Hankook Tire & Technology Co., Ltd. 55 The United States of America as represented by the Administrator of the National Aeronautics and Space Administration 55 Melexis Technologies NV 55

Similar claim depth

Nearest assignees by average claims per patent (11.5 here).

J. Morita MFG. Corp. 11.5 avg Suteng Innovation Technology Co., Ltd. 11.5 avg New Shicoh Motor Co., Ltd. 11.5 avg Kagoshima University 11.5 avg

Allergan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Allergan, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	141	23.0%
2016	125	20.4%
2017	95	15.5%
2018	60	9.8%
2019	68	11.1%
2020	50	8.2%
2021	38	6.2%
2022	17	2.8%
2023	7	1.1%
2024	8	1.3%
2025partial year	3	0.5%

Which technologies does Allergan, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 415

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 402

C07D - Heterocyclic Compounds 142

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 90

C07K - Peptides 85

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 78

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 68

C12Y - Enzymes 67

C07C - Acyclic OR Carbocyclic Compounds 54

Y02A - Technologies FOR Adaptation TO Climate Change 46

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 42

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 33

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 25

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 20

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 17

Top 15 of 57 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Allergan, Inc.'s patent record in context - here's where to go next.

Allergan, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 67.8% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #745 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Allergan, Inc. against Suzuki Motor Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 55.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.